SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-267402
Filing Date
2021-09-08
Accepted
2021-09-08 09:23:54
Documents
7
Period of Report
2021-09-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d205453d8k.htm 8-K 23415
2 EX-10.1 d205453dex101.htm EX-10.1 32079
3 EX-99.1 d205453dex991.htm EX-99.1 8497
4 GRAPHIC g205453dsp006b.jpg GRAPHIC 2596
5 GRAPHIC g205453g0003.jpg GRAPHIC 3297
6 GRAPHIC g205453g002.jpg GRAPHIC 3889
7 GRAPHIC g205453g01.jpg GRAPHIC 1971
  Complete submission text file 0001193125-21-267402.txt   82016
Mailing Address 14193 NW 119TH TERRACE SUITE #10 ALACHUA FL 32615
Business Address 14193 NW 119TH TERRACE SUITE #10 ALACHUA FL 32615 386-462-2204
APPLIED GENETIC TECHNOLOGIES CORP (Filer) CIK: 0001273636 (see all company filings)

IRS No.: 593553710 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-36370 | Film No.: 211240891
SIC: 2836 Biological Products, (No Diagnostic Substances)